Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
biochemistry, including the expression and purification of recombinant proteins and the functional analysis of proteins is desired. Experience in cell biology, including CRISPR/Cas9 approaches
-
and Parkinson’s Disease. To this end, we have established a CRISPR-based functional genomics platform for genetic screens in both human iPSC-based and murine models of disease (Tian et al., 2019, Neuron
-
acute and chronic drug effects on muscle signalling and metabolism across muscle types, and in engineered human muscle tissue; use inducible CRISPR/AAV-mediated muscle-specific gene targeting to identify
-
of science – ranging from antibiotics to DNA structure, CRISPR-Cas9, and modern pharmacotherapies – the project examines contexts of emergence, participation structures, and the “moment of creative
-
Departments and Centers: Surgery, General Surgery Postdoc Appointment Term: 1 year Appointment Start Date: June 1st, 2026 Group or Departmental Website: https://cepikalab.figma.site/ (link is
-
organoid systems with functional assays, flow cytometry, advanced imaging, and high-dimensional approaches, including single-cell and spatial transcriptomics and epigenomics. More details: https
-
Albert Einstein College of Medicine (Bronx, NY) | New York City, New York | United States | about 5 hours ago
stem cells. 2) Functional genomics of noncoding regulatory variation Projects will use massively parallel reporter assays, CRISPR-based screens, and genome editing to test noncoding variants, map
-
( https://www.hsph.harvard.edu/lin-lab/ ), Professor of Biostatistics and Professor of Statistics. The postdoctoral fellow will develop and apply statistical, machine learning (ML), and AI methods
-
( https://www.hsph.harvard.edu/lin-lab/ ), Professor of Biostatistics and Professor of Statistics. The postdoctoral fellow will develop and apply statistical, machine learning (ML), and AI methods
-
editing techniques to investigate how super-enhancer dysregulation contributes to B-cell acute lymphoblastic leukaemia. The project applies sophisticated gene editing techniques such as CRISPR